🇺🇸 FDA
Patent

US 6096534

Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells

expired A61KA61K48/00

Quick answer

US patent 6096534 (Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K48/00